NCT06615817Not yet recruiting
Intermittent Fasting, Mediterranean Diet and NAFLD
Comparison Between 14/10 Intermittent Fasting and the Southern Italian Mediterranean Diet in the Variation of NAFLD Score, Inflammatory Indices and Intestinal Microbiota
Source: ClinicalTrials.gov · Last updated 26 Oct 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to evaluate the effects of Intermittent Fasting (IF) 14/10 compared with the Low Glycemic Index Mediterranean Diet on NAFLD.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 18 Sept 2024
- Start date
- 1 Jan 2025
- Primary completion date
- 1 Jan 2026
- Lead sponsor
- Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
- Diseases
- Obesity, Fatty liver disease (MASLD/MASH)
- NCT number
- NCT06615817
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 1 Jan 2025 to the primary completion date, 1 Jan 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- diabetes treated with insulin,
Other illness
- fatty liver disease linked to alcohol consumption,
- chronic inflammatory intestinal and oncological diseases,
- subjects in serious medical conditions that may compromise participation in the trial,
Other
- visceral obesity which does not allow good resolution of Fibroscan images,
- people following a special diet or unable to follow a diet for religious or other reasons.
- Pregnancy and breastfeeding
Who the study is looking for
- Medium/severe NAFLD (CAP\>268)
- BMI between 25 and 35
Age in the registry: 30 years to 65 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.